Oriental Wave Holdings

Oriental Wave Holdings is a biotechnology and medical device company specializing in the field of regenerative medicine and aesthetic healthcare. The company focuses on the development and distribution of advanced cell therapy solutions, most notably Platelet-Rich Plasma (PRP) systems and automated cell processing technologies. Headquartered in Hong Kong, Oriental Wave serves as a strategic bridge for innovative medical technologies, particularly those originating from Japan, into the Greater China and Asia-Pacific markets. Their product portfolio supports clinical applications in dermatology, orthopedics, and sports medicine, providing tools for tissue repair and anti-aging treatments.